Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

NCT05597345 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Smoldering Multiple Myeloma

Interventions

DRUG: Selinexor

Sponsor

University of Rochester

Collaborators

[object Object]